- Home
- QTRX
as of 12-05-2025 3:46pm EST
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 337.7M | IPO Year: | 2017 |
| Target Price: | $10.33 | AVG Volume (30 days): | 875.4K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.05 - $12.94 | Next Earning Date: | 11-10-2025 |
| Revenue: | $130,203,000 | Revenue Growth: | -2.69% |
| Revenue Growth (this year): | -1.16% | Revenue Growth (next year): | 28.28% |
AI-Powered QTRX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Quanterix Corporation (QTRX)
Chief Financial Officer
Avg Cost/Share
$4.79
Shares
4,150
Total Value
$19,878.50
Owned After
87,200
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Sriram Vandana | QTRX | Chief Financial Officer | Sep 12, 2025 | Buy | $4.79 | 4,150 | $19,878.50 | 87,200 |
Compare QTRX vs Leading Stocks
See how QTRX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "QTRX Quanterix Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.